Trial intelligence / Profile preview

Acetadote EF vs Acetadote in acetaminophen overdose

NCT01118663Phase 3Terminated

Sponsor
Cumberland Pharmaceuticals
Start
Sep 2010
Primary completion
Nov 2012
Countries
1
01

Overview

A Phase 3 trial of acetylcysteine in acetaminophen toxicity, sponsored by Cumberland Pharmaceuticals. Started Sep 2010; status: terminated.

02

Drugs

acetylcysteine
03

Conditions

acetaminophen toxicity

Beyond the preview

Go deeper on NCT01118663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01118663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call